Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells

Cancer Science

Volumn 104, Issue 9, 2013, Pages 1172-1177

  Kim, Rae Kwon ^a   Suh, Yongjoon ^a   Cui, Yan Hong ^a   Hwang, Eunji ^a   Lim, Eun Jung ^a   Yoo, Ki Chun ^a   Lee, Ga Haeng ^a   Yi, Joo Mi ^b   Kang, Seok Gu ^c   Lee, Su Jae ^a  

^a Hanyang University   (South Korea)

^b Dongnam Institute of Radiological and Medical Science   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CELL DEDIFFERENTIATION; CELL POPULATION; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IONIZING RADIATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECEPTOR UPREGULATION; STEM CELL EXPANSION;

AGED; BRAIN NEOPLASMS; CELL LINE, TUMOR; DOSE FRACTIONATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GLIOBLASTOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RADIOTHERAPY; UP-REGULATION;

EID: 84883459098     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12207     Document Type: Article

References (30)

1. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005; 64: 479-89.
2. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003; 361: 323-31.
3. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002; 64: 259-73.
4. Dirks PB. Brain tumor stem cells: bringing order to the chaos of brain cancer. J Clin Oncol 2008; 26: 2916-24.
5. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 2004; 4: 737-47.
6. Ross GM. Induction of cell death by radiotherapy. Endocr Relat Cancer 1999; 6: 41-4.
7. Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 2010; 18: 619-29.
8. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
9. Galli R, Binda E, Orfanelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-21.
10. Salmaggi A, Boiardi A, Gelati M et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006; 54: 850-60.
11. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006; 6: 521-34.
12. Bakshi A, Nag TC, Wadhwa S, Mahapatra AK, Sarkar C. The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci 1998; 155: 196-203.
13. Hussain SP, Trivers GE, Hofseth LJ et al. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res 2004; 64: 6849-53.
14. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-85.
15. Lancaster JR Jr, Xie K. Tumors face NO problems? Cancer Res 2006; 66: 6459-62.
16. Eyler CE, Wu Q, Yan K et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011; 146: 53-66.
17. Jenkins DC, Charles IG, Thomsen LL et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92: 4392-6.
18. Soeda A, Inagaki A, Oka N et al. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 2008; 283: 10958-66.
19. Ing DJ, Zang J, Dzau VJ, Webster KA, Bishopric NH. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res 1999; 84: 21-33.
20. Zhang M, Atkinson RL, Rosen JM. Selective targeting of radiation-resistant tumor-initiating cells. Proc Natl Acad Sci USA 2010; 107: 3522-7.
21. Frosina G. DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res 2009; 7: 989-99.
22. Muto J, Imai T, Ogawa D et al. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways. PLoS ONE 2012; 7: e33431.
23. Zhang M, Song T, Yang L et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 2008; 27: 85.
24. Lorenzo IM, Fleischer A, Bachiller D. Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells. Stem Cell Rev 2012; doi: 10.1007/S12015-012-9412-5 [Epub ahead of print].
25. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
26. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
27. Taylor MD, Poppleton H, Fuller C et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005; 8: 323-35.
28. Kim SY, Kang JW, Song X et al. Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells. Cell Signal 2013; 25: 961-9.
29. Yang G, Quan Y, Wang W et al. Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations. Br J Cancer 2012; 106: 1512-9.
30. Charles N, Ozawa T, Squatrito M et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 2010; 6: 141-52.